Aviitam
1 paper1 finding
- 1 lab in 1 country
- 1 of 1 finding with company ties
- Humans1
Associations
1Semaglutide
upin humans1OR 1.62
1 study
Semaglutide
upin humans1OR 1.62
Aviitam is associated with semaglutide in humans (adjusted OR 1.62, 95% CI 1.05-2.50).
“each engagement increment was associated with higher odds of persistence (adjusted odds ratio 1.62, 95% CI 1.05-2.50; P=.03)”
Humansinitiating semaglutide 2.4 mg/week for severe obesity48 weeksn = 191
Journal of medical Internet research26 Aug 2026
Latest
1 in 12 monthsJournal of Medical Internet Research
Digital Engagement and Predictors of Semaglutide Persistence and Weight Loss in Severe Obesity: 48-Week Observational Study
Cohort study of 191 peopleObesity